However, according to a great need for screening the only widely accessible method is to determine ALT level (two times the age-specific upper normal level) in at-risk populations: overweight children, and those with diabetes type 2 and dyslipidemias [26]. The gene discussed is GPT; the disease is type 2 diabetes mellitus.